Jun 2, 2025 05:40AM Sanofi to acquire Blueprint Medicines, $129 per share

May 2, 2025 05:51AM Citizens JMP Reiterates Market Outperform Rating on Blueprint Medicines (BPMC)

May 1, 2025 07:04AM Blueprint Medicines (BPMC) Tops Q1 EPS by 50c ; Offers Guidance

Apr 28, 2025 07:47AM Blueprint Medicines (BPMC) PT Lowered to $130 at Needham

Apr 21, 2025 04:22AM Citizens JMP Reiterates Market Outperform Rating on Blueprint Medicines (BPMC)

Mar 20, 2025 03:24AM Morgan Stanley Assumes Blueprint Medicines (BPMC) at Equalweight

Mar 18, 2025 04:38AM Wolfe Research Starts Blueprint Medicines (BPMC) at Outperform

Mar 17, 2025 01:04AM Jefferies Starts Blueprint Medicines (BPMC) at Buy

Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma

Mar 7, 2025 07:09AM Scotiabank Starts Blueprint Medicines (BPMC) at Sector Outperform

Mar 3, 2025 04:42AM Citizens JMP Reiterates Market Outperform Rating on Blueprint Medicines (BPMC)

Feb 20, 2025 09:32AM Stifel Reiterates Buy Rating on Blueprint Medicines (BPMC)

Feb 18, 2025 04:19AM JMP Securities Reiterates Market Outperform Rating on Blueprint Medicines (BPMC)

Feb 14, 2025 04:14AM JMP Securities Reiterates Market Outperform Rating on Blueprint Medicines (BPMC)

Feb 13, 2025 07:02AM Blueprint Medicines (BPMC) Misses Q4 EPS by 9c ; Offers Guidance

Feb 3, 2025 01:25PM Raymond James Reiterates Strong Buy Rating on Blueprint Medicines (BPMC)

Jan 27, 2025 07:51AM Blueprint Medicines (BPMC) PT Raised to $119 at Piper Sandler

Jan 23, 2025 03:08PM Blueprint Medicines (BPMC) buyer of 4700 contracts of February 105 puts for $4.60

Jan 7, 2025 11:20AM Stifel Reiterates Buy Rating on Blueprint Medicines (BPMC)

Nov 30, 2024 10:00PM JPMorgan is out with its 2025 outlook for biotech stocks

Nov 14, 2024 04:30AM JPMorgan Starts Blueprint Medicines (BPMC) at Overweight

Nov 4, 2024 03:04PM Blueprint Medicines (BPMC) call put ratio 1 call to 5.3 puts with a focus on 3K contracts of December 100 puts trading

Oct 31, 2024 07:19AM Blueprint Medicines (BPMC) PT Raised to $135 at Needham

Oct 30, 2024 12:35PM Stifel Reiterates Buy Rating on Blueprint Medicines (BPMC)

Oct 30, 2024 07:03AM Blueprint Medicines (BPMC) Tops Q3 EPS by 7c ; Offers Guidance

Oct 24, 2024 04:04AM UBS Starts Blueprint Medicines (BPMC) at Neutral

Sep 19, 2024 03:58PM Stifel on Blueprint Medicines (BPMC): 'We think fear around Ayvakit's growth offers an attractive entry point that may not last'

Aug 1, 2024 12:14PM Blueprint Medicines (BPMC) PT Raised to $155 at Stifel

Aug 1, 2024 07:06AM Blueprint Medicines (BPMC) Tops Q2 EPS by 49c ; Offers Guidance

Jul 8, 2024 08:59AM Blueprint Medicines (BPMC) PT Raised to $125 at Oppenheimer